Development of an Aryloxazole Derivative as a Brain-Permeable Anti-Glioblastoma Agent
Seulgi Shin(Convergence Research Center for Diagnosis Treatment and Care System of Dementia), Yun Kyung Kim(Korea University)
Cited by 3
Related Papers
Glioblastoma-secreted soluble CD44 activates tau pathology in the brain
|Experimental & Molecular Medicine|2018|43
An amphiphilic material arginine–arginine–bile acid promotes α-synuclein amyloid formation
|Nanoscale|2023|10
EBP1 potentiates amyloid β pathology by regulating γ-secretase
|Nature Aging|2025|3